Preparing For A Shutdown: US FDA To Retain 81% Of Workforce, Thanks Mostly To User Fees

However, user fee carryover balances will not last forever and service cuts are inevitable if a shutdown lingers for several weeks.

A prolonged government shutdown would deplete the FDA's user fee reserves. • Source: Shutterstock

The US Food and Drug Administration would furlough less than 20% of its workforce if the government shuts down on 1 October, but that number likely will increase if a funding lapse persists for several weeks.

Shutdown plans indicate 11,973 of the 15,602 staff retained (77%), if government funding is not renewed by the end of the fiscal year, would be those who can be...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Observational, Retrospective Trials Could Retest Vaccines, HHS’ Kennedy Says

20 May 2025

• By Derrick Gingery

The Health and Human Services secretary told a Senate appropriations subcommittee that placebo-controlled trials may not be necessary to ensure vaccine safety as the FDA released a framework requiring them for COVID-19 vaccines.

UK MHRA’s Clinical Trial Lead On Combined Reviews, The Notification Scheme & Increasing Diversity

20 May 2025

• By Eliza Slawther

In light of the UK’s MHRA announcing a major overhaul of its clinical trial legislation, the agency’s deputy director for clinical investigations and trials Andrea Manfrin tells the Pink Sheet what sponsors can expect from the new regulation.